After a median follow-up of @ months , the median overall survival was @ months longer with ADT plus docetaxel ( combination therapy ) than with ADT alone ( @ months vs. @ months ; hazard ratio for death in the combination group , @ ; @ % confidence interval -LSB- CI -RSB- , @ to @ ; P < @ ) .